about
Genomic and epigenomic heterogeneity in molecular subtypes of gastric cancerUpregulation of miR-125b is associated with poor prognosis and trastuzumab resistance in HER2-positive gastric cancer.Identifying therapeutic targets in gastric cancer: the current status and future directionExpression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1 and 3 in Gastric and Esophageal Adenocarcinoma.State of the art in anti-cancer mAbs.Receptor tyrosine kinase amplified gastric cancer: Clinicopathologic characteristics and proposed screening algorithmMET overexpression, gene amplification and relevant clinicopathological features in gastric adenocarcinoma.Combating acquired resistance to trastuzumab by an anti-ErbB2 fully human antibody.High expression of Wls is associated with lymph node metastasis and advanced TNM stage in gastric carcinomas.Targeted therapy in esophageal cancer.Inhibitory effects of bevacizumab monoclonal antibodies in combination with chemotherapy in different time sequences on a human gastric carcinoma cell line.Monoclonal antibodies for treating gastric cancer: promises and pitfalls.High expression of EGFR predicts poor survival in patients with resected T3 stage gastric adenocarcinoma and promotes cancer cell survivalDCT015, a new sorafenib derivate, inhibits tumor growth and angiogenesis in gastric cancer models.Expression of p-STAT3 and vascular endothelial growth factor in MNNG-induced precancerous lesions and gastric tumors in ratsNF-κB Signaling in Gastric Cancer.C-C motif chemokine receptors in gastric cancer.Low angiomotin-p130 with concomitant high Yes-associated protein 1 expression is associated with adverse prognosis of advanced gastric cancer.Antiproliferative effects of the CDK6 inhibitor PD0332991 and its effect on signaling networks in gastric cancer cells.Effects of miR‑138‑5p and miR‑204‑5p on the migration and proliferation of gastric cancer cells by targeting EGFR.
P2860
Q26774509-95105195-52DD-4C79-8C30-851871B5B8A8Q33846816-E6118B43-E047-4BDA-8F78-61C2B69DDB3EQ36398732-23A0AC3D-A2BA-4272-98E7-14E729484CADQ36547753-F62DAE23-E8B3-4839-818C-FD20454FA215Q37655585-631E7B4E-EE5D-4B53-A233-6C8397C93332Q37687784-61818EDD-161D-4AF4-B391-72EE877865FAQ37705824-5DD4BF4F-B9E0-407A-B212-30DCC0FAEB45Q38703210-5C7E2A14-2209-4583-8763-A6BCDCDD38F6Q38720109-A901634F-BA4C-47D4-8875-8FBA1525AF6CQ38741042-CF0A1801-4379-4A97-B41B-8B2040198295Q38761344-9D2C2698-D0E6-4674-A347-3EF2A56C0E98Q38772049-9134A81A-A8A1-439F-BDC9-21DE300EF426Q38776722-947E7939-52BD-46D0-AC87-CF9F41D49631Q38803566-D7C6F8DF-D4AD-4B20-80D2-1B11FFD20971Q38965315-8771180F-07E4-468C-BB69-3AB6476A8107Q39204794-AAE0556C-124E-4FE6-9FEC-31EC64BE6AE2Q47163024-42F93045-9ECF-4F5C-9AAE-ABCD2830D341Q47834790-C15B3A14-C88F-4121-8BAE-C8836DE53F92Q50047971-97844688-6B6B-41DB-9FCC-E832A6C9E643Q55113730-D83E96B6-C258-4C0D-BE8B-F3DAEF5DA103
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Targeted therapy in gastric cancer.
@en
type
label
Targeted therapy in gastric cancer.
@en
prefLabel
Targeted therapy in gastric cancer.
@en
P2860
P356
P1476
Targeted therapy in gastric cancer.
@en
P2093
Alexandra Thiel
Ari Ristimäki
P2860
P304
P356
10.1111/APM.12359
P577
2015-02-23T00:00:00Z